Leadership

 

Laura Bosworth, CEO and co-founder, is a dynamic former Fortune 50 executive with nearly 30 years of cross-functional industry experience. She has over 20 years in product, process and service development at both the engineering and marketing level.

With a B.S. in Engineering, she started her career in manufacturing process development and quickly moved into management. She honed her product development skills leading custom software projects that included creation and execution of multiple technical sales support functions, enabling over $500M in sales. She was frequently recognized for her contributions to sales and her ability to understand customer pain-points led her to leadership roles in product marketing. She launched several new business start-ups, such as professional services, within a larger corporation and has expertise in customer support services. Using her cross-functional and international experience, she developed corporate wide quality strategies that reduced operating costs by ~$120M and improved customer satisfaction by 40-50%.

Ms. Bosworth is active, in Board positions as well as providing direct service, for numerous non-profits, primarily supporting women’s needs in the STEM field, entrepreneurship as well as domestic violence. She was a Spanish interpreter at a Volunteer Healthcare Clinic that serves low-income individuals.

Lindsay Sulzer, PhD, Director of Product Development has 14 years of research experience in regenerative medicine relevant to multiple clinical applications. As a member of the TeVido team since 2013, she has established protocols for isolating and expanding epidermal cells and improved a hydrogel prototype for cellular therapy delivery for vitiligo.  In her current role, she focuses on optimizing the cell isolation and storage procedures, developing appropriate quality tests and systems, determining necessary facilities and equipment, procuring high quality raw materials, and validating all components of the process. During graduate work at Northwestern University she created a tissue engineered hydrogel for transplanting islet cells and tracking the degradation in vivo via novel MRI contrast agents. At the University of Zurich, during her post-doctoral research, she developed hydrogels for bone and intervertebral disc regeneration that included delivery of both small molecule and protein-based therapeutics.  She has a BS in Chem. E. from Princeton University.  She has extensive experience in biomaterials, and a wide range of analytical and laboratory techniques.

Dr. Sulzer's history as a process engineer at Intel provides valuable expertise in specialty product manufacturing, including clean room standards, equipment troubleshooting, root cause analysis, quality control, cost management, implementing standard operating procedures, technician training, and maintaining equipment to specifications.

Advisors

 

Dr. John Harris

Dr. John Harris, is an Assistant Professor in the Dermatology Division, Department of Medicine at the University of Massachusetts Medical School (UMMS) in Worcester, MA. Dr. Harris directs the Vitiligo Clinic and Research Center at UMMS, which incorporates a specialty clinic for the diagnosis and treatment of patients with vitiligo, as well as a vitiligo research laboratory. He uses basic, translational, and clinical research approaches to better understand autoimmunity in vitiligo, with a particular focus on developing more effective treatments.

More Details on Dr. Harris work with vitiligo

Dr. Ben Walthall brings over 30 years of varied experience in new technology and product development.  Dr. Walthall served as VP of R&D for Zimmer Biologics where he was responsible for directing biologic and drug delivery R&D in areas such as bone healing, spinal disc regeneration, restoration of soft tissue function, and cartilage repair.  While at J&J,  he developed technologies to clinically utilize novel tissue engineering scaffold for skin repair and advanced wound care. He created a new tissue regeneration business for J&J and developed product regulatory strategies.  Early in his career, at a Biopharmaceutical company specializing, in cell transplantation and gene therapy modalities, he developed technologies for culture and

Michael Matula holds a PhD in BioChemistry and JD from The University of Texas. He has been a practicing attorney and businessman with experience in real estate development, oil & gas exploration and services, investments, and law. From 2004 to 2009 he was President & CEO of an oilfield services company in Carthage, Texas. He is an active angel investor and a former member of Central Texas Angel Network. He has invested in over 40 early stage companies across a broad range of industries. He has led several life sciences deals and currently sits on the board of Paratus Diagnostics.

Dr. Rick Schultz is a Senior Physician Executive and board-certified orthopedic surgeon. For most of his 25-plus year career, he worked at Baylor Scott and White, the largest healthcare system in Texas.  Dr. Schultz held multiple leadership positions, including Chief of Staff, Chief of Surgery, Chief Medical Officer and multiple Medical Director positions, while serving as a teaching clinical professor at the Texas A&M Medical School.   He enjoyed the challenges of combining direct patient care, physician leadership and system level executive positions.

In these roles, he screened numerous new medical technologies, assessing their potential fit into the medical system and recommending ways to overcome challenges in implementation.  This experience is an ideal fit for his role as the 2018 lead for the Life Science Sector Industry Group for the Central Texas Angel Network (CTAN).  CTAN is the largest angel investing group in Texas, and was the #1 most active single-chapter group in the nation (2016 & 2015).

Dr. Schultz received his undergraduate degree from Rice University, medical degree from Baylor College of Medicine and completed the Scott & White Orthopedic Surgery Residency Program.

Francisco Agullo, M.D., is certified by the American Board of Plastic Surgery and the American Board of Surgery. He has joined El Paso Cosmetic Surgery as a plastic surgeon serving the cosmetic needs of West Texas, New Mexico, and Northern Mexico.

Dr. Frank Agullo graduated from the world-famous Mayo Clinic in Rochester, Minnesota, and he stays current in all of the latest aesthetic procedures and technologies. Dr. Agullo also holds the position of clinical assistant professor at Texas Tech University.